The outlook for MLPs is rosy, according to Elvira Scotto, a director at RBC. In a report on the sector published by The Wall Street Transcript, Scotto says that thanks to low interest rates, MLPs have ready access to capital and can thus easily fund growth. This is good news for yield-starved investors as MLPs offer handsome payouts. Previously: MLPs will outperform even if rates rise. [View news story]
I'd be fine with their changing to C-Corps as most of my investable money is in IRA's and this would simplify things.
Battle Of The Big Oils: Which Has The Better Balance Sheet, Exxon Mobil Or Chevron? [View article]
I've been meaning to take an accounting class, but your article is really excellent; I understood it fine. However, I'm surprised to read that when companies buy back their stock it isn't really retired. Having lots of treasury stock seems like a large negative, as it's a potential diluting factor if they decide to release that stock. I'm long XOM, but I think it's about time I bought some CVX too.
WisdomTree's (WETF) dividend-weighted approach has its emerging-market dividend ETF (DEM) smoking its better-endowed competition (EEM, VWO). Up 7.7% annualized over 5 years (compared to about 2% for the other two), DEM's approach has it tilting to smaller value stocks with high yields. It's working for WisdomTree the stock as well, +46% YTD. [View news story]
I compared using TD Ameritrade. But after further consideration, I bought MXF, a closed end fund trading at a small discount to NAV; they pay a hefty dividend and have been growing nicely (24%/yr for last 10 years). Their dividend for the next year, and they pay it quarterly, is computed as 10% of the NAV as of the last trading day of the previous year, ie, 12/30/12, which was 30.81. The fund's price is about a 1% discount to NAV right now.
WisdomTree's (WETF) dividend-weighted approach has its emerging-market dividend ETF (DEM) smoking its better-endowed competition (EEM, VWO). Up 7.7% annualized over 5 years (compared to about 2% for the other two), DEM's approach has it tilting to smaller value stocks with high yields. It's working for WisdomTree the stock as well, +46% YTD. [View news story]
I appreciate this article pointing this out; I looked at DEM vs EEM vs VWO (which used to be almost identical to EEM but has changed a bit) and DEM has lower risk and higher return for 3 and 5 yr periods, about the same for the one year. I'm going to move out of VWO and into DEM.
Amazon's Margin Myth: Sleight Of Hand [View article]
1P is first party sales, ie, Amazon selling directly to customers; 3P is 3rd party sales, where Amazon is the middleman and gets a fee for the sale. Amazon is the last of the dot coms to keep the dot com valuation: they'll make their money down the road.
Time for Chewbacca's solo: Disney (DIS) CEO Bob Iger drops a nugget on the CNBC crew during his post-earnings pep session. The exec says the company will develop stand-alone films using Star Wars characters with a slate of movies tentatively scheduled for release between 2015 and 2021. [View news story]
I'm surprised that that Disney thinks that the Star Wars movie could do very many spinoffs. Chewbacca was never a developed character, nor were most of the characters, as much as they tried to interest the viewers in Jar Jar Binks. And those that were (Luke, Han, Prcs. Leia, Darth, Yoda and Obi-wan), IMHO, would do better to stand together in sequels.
Why Qualcomm's First Quarter Was Fantastic [View article]
Unfortunately, there are many stocks like that, and they keep going up and up anyway. Look at visa, mastercard, starbucks; I bought QCOM a year ago at 59.5 and it hasn't done that much sharewise - about what the S&P did. So I think it's a better deal now than it was when I bought it; I'm thinking of adding more.
Disney: The Force Is Strong With This One [View article]
This is a great article. DIS has a fantastic franchise with a solid moat. The name is magical for boomers who grew up with them. They also have a growing cruise line operation. Hopefully, they'll continue to increase the dividend at a rapid rate, but I'll continue to own them as they seem to have a good idea of what to do with FCF/retained earnings.
Pfizer (PFE) animal-health spin-off Zoetis (ZTS) forecasts annual growth of 5.7% through 2016, CEO Juan Ramon Alaix tells Bloomberg. He points out that drug failure rates are lower than with human medicines, as there are fewer safety concerns and because animals don't live as long. "Side effects are very rare in our industry, especially in livestock," Alaix says. Zoetis had a stonking NYSE debut on Friday, jumping 19% to close at $31.01 for a market cap of $15.51B. [View news story]
If Pfizer sells it for a good price, then Pfizer the company will be worth more than before. If they waste the money they receive, then it will indeed have been a diminished asset.
More details on Caterpillar (CAT): The company says the long-running accounting scheme was run by several senior managers, and was deliberate and well coordinated. It involved inflating profits at a unit of ERA Mining Machinery Ltd., a mining equipment company in China that it purchased last year. CAT paid ERA as much as $734M last June. It's removed those involved and installed a new leadership team there. Responsibilities for Siwei's manufacturing operations have been moved to CAT's China operations division, while its sales and support team will report to its global mining general manager for China and Korea. [View news story]
If CAT can't tell fraud in Chinese accounting, I don't see any reason to risk buying a Chinese stock. And I say this after buying one and watching it lose 50% of its value, foolishly.
If You Like Dividends, You'll Love Targa Resources Partners [View article]
This article is very confused; I bought NGLS in 9/2008, so it's been around a bit longer than 2010. Also, the last four distributions have been .6025, .6225, .6425, .6625 in 1/2012, 4/2012, 7/2012 and 10/2012. So I'm not sure where your figure of .06 and .42 came from - I think you're mixing up TRGP and NGLS. But NGLS has been a great performer for these last four years, and has a strong management team, so I'm hoping for more of the same in the future.
Philip Morris' CEO Discusses Q1 2013 Results - Earnings Call Transcript [View article]
The Easiest Way I Know To Make Money In Stocks [View article]
The outlook for MLPs is rosy, according to Elvira Scotto, a director at RBC. In a report on the sector published by The Wall Street Transcript, Scotto says that thanks to low interest rates, MLPs have ready access to capital and can thus easily fund growth. This is good news for yield-starved investors as MLPs offer handsome payouts. Previously: MLPs will outperform even if rates rise. [View news story]
Battle Of The Big Oils: Which Has The Better Balance Sheet, Exxon Mobil Or Chevron? [View article]
This Blue Chip Dividend Stock Has Huge Dividend Growth And Goes Ex-Dividend Next Week [View article]
2009 dividend: .21
2013 dividend: .3125
Growth rate: 10.5%, not 49%
To make it a 5 year growth rate, bring in 2008, when the quarterly dividend was also .21. This makes the growth rate 8.3%.
There are many reasons to like SLB, but its dividend is far down the list.
WisdomTree's (WETF) dividend-weighted approach has its emerging-market dividend ETF (DEM) smoking its better-endowed competition (EEM, VWO). Up 7.7% annualized over 5 years (compared to about 2% for the other two), DEM's approach has it tilting to smaller value stocks with high yields. It's working for WisdomTree the stock as well, +46% YTD. [View news story]
WisdomTree's (WETF) dividend-weighted approach has its emerging-market dividend ETF (DEM) smoking its better-endowed competition (EEM, VWO). Up 7.7% annualized over 5 years (compared to about 2% for the other two), DEM's approach has it tilting to smaller value stocks with high yields. It's working for WisdomTree the stock as well, +46% YTD. [View news story]
Amazon's Margin Myth: Sleight Of Hand [View article]
Time for Chewbacca's solo: Disney (DIS) CEO Bob Iger drops a nugget on the CNBC crew during his post-earnings pep session. The exec says the company will develop stand-alone films using Star Wars characters with a slate of movies tentatively scheduled for release between 2015 and 2021. [View news story]
Why Qualcomm's First Quarter Was Fantastic [View article]
Disney: The Force Is Strong With This One [View article]
Pfizer (PFE) animal-health spin-off Zoetis (ZTS) forecasts annual growth of 5.7% through 2016, CEO Juan Ramon Alaix tells Bloomberg. He points out that drug failure rates are lower than with human medicines, as there are fewer safety concerns and because animals don't live as long. "Side effects are very rare in our industry, especially in livestock," Alaix says. Zoetis had a stonking NYSE debut on Friday, jumping 19% to close at $31.01 for a market cap of $15.51B. [View news story]
Pfizer's Zoetis Fair Valuation [View article]
More details on Caterpillar (CAT): The company says the long-running accounting scheme was run by several senior managers, and was deliberate and well coordinated. It involved inflating profits at a unit of ERA Mining Machinery Ltd., a mining equipment company in China that it purchased last year. CAT paid ERA as much as $734M last June. It's removed those involved and installed a new leadership team there. Responsibilities for Siwei's manufacturing operations have been moved to CAT's China operations division, while its sales and support team will report to its global mining general manager for China and Korea. [View news story]
If You Like Dividends, You'll Love Targa Resources Partners [View article]